Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25

被引:334
|
作者
Kusakawa, G
Saito, T
Onuki, R
Ishiguro, K
Kishimoto, T
Hisanaga, S
机构
[1] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan
[2] Tokyo Inst Technol, Fac Biosci, Lab Cell & Dev Biol, Midori Ku, Yokohama, Kanagawa 2268501, Japan
[3] Japan Womens Univ, Dept Chem & Biol Sci, Bunkyo Ku, Tokyo 1128681, Japan
[4] Mitsubishi Kasei Inst Life Sci, Tokyo 1948511, Japan
关键词
D O I
10.1074/jbc.M907757199
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclin-dependent kinase 5 (CDK5) is a unique CDK, the activity of which can be detected in postmitotic neurons. To date, CDK5 purified from mammalian brains has always been associated with a truncated form of the 35-kDa major brain specific activator (p35, also known as nck5a) of CDK5, known as p25. In this study,we report that p35 can be cleaved to p25 both in nitro and in vivo by calpain. In a rat brain extract, p35 was cleaved to p25 by incubation with Ca2+. This cleavage was inhibited by a calpain inhibitor peptide derived from calpastatin and was ablated by separating the p35.CDK5 from calpain by centrifugation. The p35 recovered in the pellet after centrifugation could then be cleaved to p25 by purified calpain. Cleavage of p35 was also induced in primary cultured neurons by treatment with a Ca2+ ionophore and Ca2+ and inhibited by calpain inhibitor I. The cleavage changed the solubility of the CDK5 active complex from the particulate fraction to the soluble fraction but did not affect the histone H1 kinase activity. Increased cleavage was detected in cultured neurons undergoing cell death, suggesting a role of the cleavage in neuronal cell death.
引用
收藏
页码:17166 / 17172
页数:7
相关论文
共 50 条
  • [41] Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability
    Wei, FY
    Tomizawa, K
    Ohshima, T
    Asada, A
    Saito, T
    Nguyen, C
    Bibb, JA
    Ishiguro, K
    Kulkarni, AB
    Pant, HC
    Mikoshiba, K
    Matsui, H
    Hisanaga, S
    JOURNAL OF NEUROCHEMISTRY, 2005, 93 (02) : 502 - 512
  • [42] Paullones are potent inhibitors of glycogen synthase kinase-3β and cyclin-dependent kinase 5/p25
    Leost, M
    Schultz, C
    Link, A
    Wu, YZ
    Biernat, J
    Mandelkow, EM
    Bibb, JA
    Snyder, GL
    Greengard, P
    Zaharevitz, DW
    Gussio, R
    Senderowicz, AM
    Sausville, EA
    Kunick, C
    Meijer, L
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (19): : 5983 - 5994
  • [43] Extracellular alpha-synuclein induces calpain-dependent overactivation of cyclin-dependent kinase 5 in vitro
    Czapski, Grzegorz A.
    Gassowska, Magdalena
    Wilkaniec, Anna
    Cieslik, Magdalena
    Adamczyk, Agata
    FEBS LETTERS, 2013, 587 (18) : 3135 - 3141
  • [44] Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes
    Taniguchi, Yoshinori
    Pippin, Jeffrey W.
    Hagmann, Henning
    Krofft, Ronald D.
    Chang, Alice M.
    Zhang, Jiong
    Terada, Yoshio
    Brinkkoetter, Paul
    Shankland, Stuart J.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2012, 302 (09) : F1161 - F1171
  • [45] Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain
    Takashima, A
    Murayama, M
    Yasutake, K
    Takahashi, H
    Yokoyama, M
    Ishiguro, K
    NEUROSCIENCE LETTERS, 2001, 306 (1-2) : 37 - 40
  • [46] p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway
    Patrick, GN
    Zhou, PB
    Kwon, YT
    Howley, PM
    Tsai, LH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) : 24057 - 24064
  • [47] Docking and 3D-QSAR modeling of cyclin-dependent kinase 5/p25 inhibitors
    Ul Haq, Zaheer
    Uddin, Reaz
    Wai, Lam Kok
    Wadood, Abdul
    Lajis, Nordin Haji
    JOURNAL OF MOLECULAR MODELING, 2011, 17 (05) : 1149 - 1161
  • [48] The effect of 'binge' cocaine administration on the expression of cyclin-dependent kinase 5 and its activator p35 in various regions of rat brain
    Wedzony, K
    Markowicz-Kula, K
    Chocyk, A
    Fijal, K
    Mackowiak, M
    BRAIN RESEARCH, 2005, 1063 (02) : 195 - 200
  • [49] Expression of cyclin-dependent kinase 5 and its activator p35 in models of induced apoptotic death in neurons of the substantia nigra in vivo
    Neystat, M
    Rzhetskaya, M
    Oo, TF
    Kholodilov, N
    Yarygina, O
    Wilson, A
    El-Khodor, BF
    Burke, RE
    JOURNAL OF NEUROCHEMISTRY, 2001, 77 (06) : 1611 - 1625
  • [50] Localization and developmental changes in the neuron-specific cyclin-dependent kinase 5 activator (p35(nck5a)) in the rat brain
    Tomizawa, K
    Matsui, H
    Matsushita, M
    Lew, J
    Tokuda, M
    Itano, T
    Konishi, R
    Wang, JH
    Hatase, O
    NEUROSCIENCE, 1996, 74 (02) : 519 - 529